Growth Suppression of Human Hepatocellular Carcinoma Xenografts by a Monoclonal Antibody CH12 Directed to Epidermal Growth Factor Receptor Variant III-Reference-Cited by-同舟云学术

Growth Suppression of Human Hepatocellular Carcinoma Xenografts by a Monoclonal Antibody CH12 Directed to Epidermal Growth Factor Receptor Variant III

Published:2011-02 Issue:7 Volume:286 Page:5913-5920
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Jiang Hua,Wang Huamao,Tan Zhonghua,Hu Suwen,Wang Hai,Shi Bizhi,Yang Lin,Li Peiyong,Gu Jianren,Wang Hongyang,Li Zonghai

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference40 articles.

1. Hepatocellular carcinoma

2. Hepatocellular carcinoma: Current management and future trends

3. Systemic Therapy of Advanced Hepatocellular Carcinoma: How Hopeful Should We Be?

4. Safety and Efficacy of Sorafenib in Patients With Advanced Hepatocellular Carcinoma in Consideration of Concomitant Stage of Liver Cirrhosis

5. Les récepteurs à Epidermal Growth Factor (REGF), une nouvelle cible thérapeutique

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, Synthesis, Anticancer Evaluation and Molecular Modeling Studies of New Thiazolidinone‐Benzoate Scaffold as EGFR Inhibitors, Cell Cycle Interruption and Apoptosis Inducers in HepG2;Chemistry & Biodiversity;2023-09-11

2. Perspectives for novel therapeutic concepts in hepatocellular carcinoma targeting the stromal and innate immune microenvironment;Liver Cancer International;2022-12-30

3. The Dietary Supplement γ-Oryzanol Attenuates Hepatic Ischemia Reperfusion Injury via Inhibiting Endoplasmic Reticulum Stress and HMGB1/NLRP3 Inflammasome;Oxidative Medicine and Cellular Longevity;2021-09-02

4. The quinazoline derivative, 04NB-03, induces cell cycle arrest and apoptosis in hepatocellular carcinoma cells in a reactive oxygen species-dependent manner;Chemico-Biological Interactions;2021-04

5. Natural Killer Cell Responses in Hepatocellular Carcinoma: Implications for Novel Immunotherapeutic Approaches;Cancers;2020-04-09